Back

Gene therapy for atrial fibrillation: a dream come true?

9 April 2024 (13:51 - 14:03)
Organised by: Logo
Congress Presentation Part of: Gene therapy for cardiac arrhythmias Arrhythmias EHRA Premium Access EHRA 2024 European Heart Rhythm Association (EHRA)

About the speaker

Photo
Professor Kevin Donahue

Umass Memorial Medical Center, Inc., Worcester (United States of America)

4 More presentations in this session

Presentation thumbnail
Long QT syndrome type 1 and type 2: which is the preferred gene therapy strategy?
Doctor M. Ackerman (Rochester, US)
Slides
Presentation thumbnail
Raising the bar: the role of preclinical models in the development of gene therapies for channelopathies
Associate Professor C. Remme (Amsterdam, NL)
Slides
Presentation thumbnail
Gene therapy strategies for Brugada syndrome: targeting protein-trafficking regulator MOG1
Professor Q. Wang (Wuhan, CN)
Slides
Presentation thumbnail
Discussion: my views on it
Doctor A. Gomez (Orsay, FR)

Access the full session

Session thumbnail
Gene therapy for cardiac arrhythmias

The Event

Event poster

EHRA 2024

9 April 2024 13:51 CET
You may be interested in
thumbnail
Congress Session
Epicardial/endocardial hybrid treatments: combining strengths, restoring rhythm
30 March 2025
thumbnail
Congress Presentation
Genetic aspects associated with increased risk of developing atrial fibrillation
15 June 2024
thumbnail
Congress Presentation
Wearable-based shock-free control of cardiac rhythm for acute ambulatory cardioversion of atrial fibrillation
12 April 2026
thumbnail
Congress Session
Novel interventions and therapies to prevent sudden arrhythmic death
30 August 2025

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources